1 |
HRH3
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D10749
D10749
|
Pitolisant
| 1件: 193 193 |
2 |
CNR1
| 4件: Rap1 signaling pathway Rap1 signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Thermogenesis 💬, Retrograde endocannabinoid signaling 💬 | D05731
D05731
|
Rimonabant
| 1件: 193 193 |
3 |
CNR1
| 4件: Rap1 signaling pathway Rap1 signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Thermogenesis 💬, Retrograde endocannabinoid signaling 💬 | D10915
D10915
|
Cannabidiol
| 19件: 2 2, 6, 8, 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 |
4 |
CNR2
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D10915
D10915
|
Cannabidiol
| 4件: 193 193, 206, 226, 271 |
5 |
ADRA2A
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬 | D00606
D00606
|
Guanfacine
| 1件: 193 193 |
6 |
ADRA2A
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬 | D08031
D08031
|
Guanfacine
| 1件: 193 193 |
7 |
ADRB1
| 11件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Gap junction 💬, Regulation of lipolysis in adipocytes 💬, Renin secretion 💬, Salivary secretion 💬, Chemical carcinogenesis - receptor activation 💬, Dilated cardiomyopathy 💬 | D00601
D00601
|
Metoprolol
| 6件: 17 17, 57, 58, 113, 193, 226 |
8 |
ADRB1
| 11件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Gap junction 💬, Regulation of lipolysis in adipocytes 💬, Renin secretion 💬, Salivary secretion 💬, Chemical carcinogenesis - receptor activation 💬, Dilated cardiomyopathy 💬 | D02358
D02358
|
Metoprolol
| 6件: 17 17, 57, 58, 113, 193, 226 |
9 |
ADRB1
| 11件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Gap junction 💬, Regulation of lipolysis in adipocytes 💬, Renin secretion 💬, Salivary secretion 💬, Chemical carcinogenesis - receptor activation 💬, Dilated cardiomyopathy 💬 | D05011
D05011
|
Metoprolol
| 6件: 17 17, 57, 58, 113, 193, 226 |
10 |
CYP11B1
| 4件: Steroid hormone biosynthesis Steroid hormone biosynthesis 💬, Metabolic pathways 💬, Cortisol synthesis and secretion 💬, Cushing syndrome 💬 | D00410
D00410
|
Metyrapone
| 2件: 75 75, 193 |
11 |
CYP11B1
| 4件: Steroid hormone biosynthesis Steroid hormone biosynthesis 💬, Metabolic pathways 💬, Cortisol synthesis and secretion 💬, Cushing syndrome 💬 | D05019
D05019
|
Metyrapone
| 2件: 75 75, 193 |
12 |
CYP19A1
| 3件: Steroid hormone biosynthesis Steroid hormone biosynthesis 💬, Metabolic pathways 💬, Ovarian steroidogenesis 💬 | D00960
D00960
|
Anastrozole
| 3件: 78 78, 86, 193 |
13 |
MTOR
| 51件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance 💬, Endocrine resistance 💬, ErbB signaling pathway 💬, HIF-1 signaling pathway 💬, Phospholipase D signaling pathway 💬, Autophagy - other 💬, Autophagy - animal 💬, mTOR signaling pathway 💬, PI3K-Akt signaling pathway 💬, AMPK signaling pathway 💬, Longevity regulating pathway 💬, Longevity regulating pathway - multiple species 💬, Cellular senescence 💬, Apelin signaling pathway 💬, Neutrophil extracellular trap formation 💬, JAK-STAT signaling pathway 💬, Th17 cell differentiation 💬, Thermogenesis 💬, Insulin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Adipocytokine signaling pathway 💬, Type II diabetes mellitus 💬, Insulin resistance 💬, Growth hormone synthesis, secretion and action 💬, Alzheimer disease 💬, Amyotrophic lateral sclerosis 💬, Huntington disease 💬, Spinocerebellar ataxia 💬, Pathways of neurodegeneration - multiple diseases 💬, Shigellosis 💬, Human cytomegalovirus infection 💬, Human papillomavirus infection 💬, Kaposi sarcoma-associated herpesvirus infection 💬, Herpes simplex virus 1 infection 💬, Human immunodeficiency virus 1 infection 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, MicroRNAs in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Colorectal cancer 💬, Pancreatic cancer 💬, Glioma 💬, Prostate cancer 💬, Acute myeloid leukemia 💬, Breast cancer 💬, Hepatocellular carcinoma 💬, Gastric cancer 💬, Central carbon metabolism in cancer 💬, Choline metabolism in cancer 💬, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬, Diabetic cardiomyopathy 💬 | D00753
D00753
|
Sirolimus
| 41件: 2 2, 6, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
14 |
GABRA1
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Taste transduction 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
15 |
GABRA2
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Taste transduction 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
16 |
GABRA3
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Taste transduction 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
17 |
GABRA4
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Taste transduction 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
18 |
GABRA5
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Taste transduction 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
19 |
GABRA6
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Taste transduction 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
20 |
GABRB1
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, Serotonergic synapse 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
21 |
GABRB2
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, Serotonergic synapse 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
22 |
GABRB3
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, Serotonergic synapse 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
23 |
GABRD
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
24 |
GABRE
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
25 |
GABRG1
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
26 |
GABRG2
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
27 |
GABRG3
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
28 |
GABRP
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
29 |
GHR
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬, Neuroactive ligand-receptor interaction 💬, PI3K-Akt signaling pathway 💬, JAK-STAT signaling pathway 💬, Growth hormone synthesis, secretion and action 💬 | D02691
D02691
|
Somatotropin
| 23件: 2 2, 3, 13, 19, 46, 65, 74, 75, 76, 78, 96, 107, 113, 187, 191, 193, 195, 236, 238, 265, 274, 276, 299 |
30 |
GLP1R
| 3件: cAMP signaling pathway cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Insulin secretion 💬 | D04121
D04121
|
Exenatide
| 6件: 6 6, 17, 72, 78, 193, 233 |
31 |
GLP1R
| 3件: cAMP signaling pathway cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Insulin secretion 💬 | D06404
D06404
|
Liraglutide
| 3件: 6 6, 75, 193 |
32 |
GRIA1
| 14件: cAMP signaling pathway cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Circadian entrainment 💬, Long-term potentiation 💬, Retrograde endocannabinoid signaling 💬, Glutamatergic synapse 💬, Dopaminergic synapse 💬, Long-term depression 💬, Amyotrophic lateral sclerosis 💬, Huntington disease 💬, Spinocerebellar ataxia 💬, Pathways of neurodegeneration - multiple diseases 💬, Amphetamine addiction 💬, Nicotine addiction 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
33 |
GRIA2
| 15件: cAMP signaling pathway cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Circadian entrainment 💬, Long-term potentiation 💬, Retrograde endocannabinoid signaling 💬, Glutamatergic synapse 💬, Dopaminergic synapse 💬, Long-term depression 💬, Amyotrophic lateral sclerosis 💬, Huntington disease 💬, Spinocerebellar ataxia 💬, Pathways of neurodegeneration - multiple diseases 💬, Cocaine addiction 💬, Amphetamine addiction 💬, Nicotine addiction 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
34 |
GRIA3
| 13件: cAMP signaling pathway cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Circadian entrainment 💬, Retrograde endocannabinoid signaling 💬, Glutamatergic synapse 💬, Dopaminergic synapse 💬, Long-term depression 💬, Huntington disease 💬, Spinocerebellar ataxia 💬, Pathways of neurodegeneration - multiple diseases 💬, Amphetamine addiction 💬, Nicotine addiction 💬, Transcriptional misregulation in cancer 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
35 |
GRIA4
| 10件: cAMP signaling pathway cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Circadian entrainment 💬, Retrograde endocannabinoid signaling 💬, Glutamatergic synapse 💬, Dopaminergic synapse 💬, Huntington disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Amphetamine addiction 💬, Nicotine addiction 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
36 |
GRIK1
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Glutamatergic synapse 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
37 |
GRIK2
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Glutamatergic synapse 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
38 |
GRIK3
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Glutamatergic synapse 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
39 |
GRIK4
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Glutamatergic synapse 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
40 |
GRIK5
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Glutamatergic synapse 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
41 |
KCNJ11
| 3件: Insulin secretion Insulin secretion 💬, GnRH secretion 💬, Type II diabetes mellitus 💬 | D00294
D00294
|
Diazoxide
| 2件: 13 13, 193 |
42 |
MC2R
| 5件: cAMP signaling pathway cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Aldosterone synthesis and secretion 💬, Cortisol synthesis and secretion 💬, Cushing syndrome 💬 | D00146
D00146
|
Corticotropin
| 15件: 2 2, 13, 14, 46, 49, 50, 66, 75, 78, 81, 84, 145, 193, 205, 222 |
43 |
OXTR
| 4件: Calcium signaling pathway Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Oxytocin signaling pathway 💬 | D00089
D00089
|
Oxytocin
| 6件: 6 6, 72, 127, 193, 206, 226 |
44 |
OXTR
| 4件: Calcium signaling pathway Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Oxytocin signaling pathway 💬 | D07229
D07229
|
Carbetocin
| 1件: 193 193 |
45 |
GABRQ
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
46 |
SCN1A
| 1件: Dopaminergic synapse Dopaminergic synapse 💬 | D00537
D00537
|
Topiramate
| 1件: 193 193 |
47 |
SCN2A
| 1件: Taste transduction Taste transduction 💬 | D00537
D00537
|
Topiramate
| 1件: 193 193 |
48 |
SCN3A
| 1件: Taste transduction Taste transduction 💬 | D00537
D00537
|
Topiramate
| 1件: 193 193 |
49 |
SCN5A
| 1件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes 💬 | D00537
D00537
|
Topiramate
| 1件: 193 193 |
50 |
SCN9A
| 1件: Taste transduction Taste transduction 💬 | D00537
D00537
|
Topiramate
| 1件: 193 193 |
51 |
SSTR2
| 4件: cAMP signaling pathway cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Growth hormone synthesis, secretion and action 💬, Gastric acid secretion 💬 | D00442
D00442
|
Octreotide
| 7件: 67 67, 75, 84, 85, 89, 193, 227 |
52 |
SSTR2
| 4件: cAMP signaling pathway cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Growth hormone synthesis, secretion and action 💬, Gastric acid secretion 💬 | D06495
D06495
|
Octreotide
| 7件: 67 67, 75, 84, 85, 89, 193, 227 |
53 |
ABCC8
| 3件: ABC transporters ABC transporters 💬, Insulin secretion 💬, Type II diabetes mellitus 💬 | D00294
D00294
|
Diazoxide
| 2件: 13 13, 193 |
54 |
CA2
| 7件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬, Proximal tubule bicarbonate reclamation 💬, Collecting duct acid secretion 💬, Gastric acid secretion 💬, Pancreatic secretion 💬, Bile secretion 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
55 |
CA4
| 3件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬, Proximal tubule bicarbonate reclamation 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
56 |
CACNA1C
| 34件: MAPK signaling pathway MAPK signaling pathway 💬, Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Cardiac muscle contraction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Circadian entrainment 💬, Long-term potentiation 💬, Retrograde endocannabinoid signaling 💬, Glutamatergic synapse 💬, Cholinergic synapse 💬, Serotonergic synapse 💬, GABAergic synapse 💬, Dopaminergic synapse 💬, Taste transduction 💬, Insulin secretion 💬, GnRH signaling pathway 💬, Oxytocin signaling pathway 💬, Renin secretion 💬, Aldosterone synthesis and secretion 💬, Cortisol synthesis and secretion 💬, GnRH secretion 💬, Type II diabetes mellitus 💬, Cushing syndrome 💬, Growth hormone synthesis, secretion and action 💬, Alzheimer disease 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Amphetamine addiction 💬, Chemical carcinogenesis - receptor activation 💬, Hypertrophic cardiomyopathy 💬, Arrhythmogenic right ventricular cardiomyopathy 💬, Dilated cardiomyopathy 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
57 |
CACNA1D
| 35件: MAPK signaling pathway MAPK signaling pathway 💬, Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Cellular senescence 💬, Cardiac muscle contraction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Tight junction 💬, Circadian entrainment 💬, Retrograde endocannabinoid signaling 💬, Glutamatergic synapse 💬, Cholinergic synapse 💬, Serotonergic synapse 💬, GABAergic synapse 💬, Dopaminergic synapse 💬, Insulin secretion 💬, GnRH signaling pathway 💬, Oxytocin signaling pathway 💬, Renin secretion 💬, Aldosterone synthesis and secretion 💬, Cortisol synthesis and secretion 💬, GnRH secretion 💬, Type II diabetes mellitus 💬, Cushing syndrome 💬, Growth hormone synthesis, secretion and action 💬, Carbohydrate digestion and absorption 💬, Alzheimer disease 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Amphetamine addiction 💬, Chemical carcinogenesis - receptor activation 💬, Hypertrophic cardiomyopathy 💬, Arrhythmogenic right ventricular cardiomyopathy 💬, Dilated cardiomyopathy 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
58 |
CACNA1F
| 27件: MAPK signaling pathway MAPK signaling pathway 💬, Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Cardiac muscle contraction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Retrograde endocannabinoid signaling 💬, Cholinergic synapse 💬, Serotonergic synapse 💬, GABAergic synapse 💬, Insulin secretion 💬, GnRH signaling pathway 💬, Oxytocin signaling pathway 💬, Renin secretion 💬, Aldosterone synthesis and secretion 💬, Cortisol synthesis and secretion 💬, GnRH secretion 💬, Cushing syndrome 💬, Growth hormone synthesis, secretion and action 💬, Alzheimer disease 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Chemical carcinogenesis - receptor activation 💬, Hypertrophic cardiomyopathy 💬, Arrhythmogenic right ventricular cardiomyopathy 💬, Dilated cardiomyopathy 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
59 |
CACNA1S
| 27件: MAPK signaling pathway MAPK signaling pathway 💬, Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Cardiac muscle contraction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Retrograde endocannabinoid signaling 💬, Cholinergic synapse 💬, Serotonergic synapse 💬, GABAergic synapse 💬, Insulin secretion 💬, GnRH signaling pathway 💬, Oxytocin signaling pathway 💬, Renin secretion 💬, Aldosterone synthesis and secretion 💬, Cortisol synthesis and secretion 💬, GnRH secretion 💬, Cushing syndrome 💬, Growth hormone synthesis, secretion and action 💬, Alzheimer disease 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Chemical carcinogenesis - receptor activation 💬, Hypertrophic cardiomyopathy 💬, Arrhythmogenic right ventricular cardiomyopathy 💬, Dilated cardiomyopathy 💬 | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |